Oligosymptomatic long-term carriers of SARS-CoV-2 display impaired innate resistance but increased high-affinity anti-spike antibodies.
Montes-Cobos E, Bastos VC, Monteiro C, de Freitas JCR, Fernandes HDP, Constancio CS, Rodrigues DAS, Gama AMDS, Vidal VM, Alves LS, Zalcberg-Renault L, de Lira GS, Ota VA, Caloba C, Conde L, Leitão IC, Tanuri A, Ferreira ODC, Pereira RM, Vale AM, Castiñeiras TM, Kaiserlian D, Echevarria-Lima J, Bozza MT.
Montes-Cobos E, et al.
iScience. 2023 Jun 28;26(7):107219. doi: 10.1016/j.isci.2023.107219. eCollection 2023 Jul 21.
iScience. 2023.
PMID: 37529320
Free PMC article.